| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Norgestrel | FAERS: 6 | US FAERS | |
| 2 | NuvaRing | FAERS: 5 | US FAERS | |
| 3 | tesamorelin | FAERS: 3 | US FAERS | |
| 4 | Maraviroc | FAERS: 2 | OFFSIDES US FAERS | |
| 5 | Budesonide | FAERS: 1 | US FAERS | |
| 6 | Isotretinoin | FAERS: 1 | US FAERS | |
| 7 | Methotrexate | FAERS: 1 | US FAERS | |
| 8 | Tacrolimus | FAERS: 1 | US FAERS | |
| 9 | Acenocoumarol | OFFSIDES | ||
| 10 | Atazanavir Sulfate | OFFSIDES | ||
| 11 | Didanosine | OFFSIDES | ||
| 12 | Indinavir | OFFSIDES | ||
| 13 | Nelfinavir | OFFSIDES | ||
| 14 | Stavudine | OFFSIDES | ||
| 15 | Tenofovir | OFFSIDES | ||
| 16 | Zidovudine | OFFSIDES | ||
| 17 | amprenavir | OFFSIDES | ||
| 18 | efavirenz | OFFSIDES | ||
| 19 | fosamprenavir | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.